Comments
Loading...
ImmuCell (NASDAQ:ICCC) Stock, Earnings Estimates, EPS, And Revenue
ImmuCell reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Nov 13
EPS
$-0.090
Quarterly Revenue
$6.01M
Annual Revenue
(as of Sep 30)
(as of Sep 30)
$23.84M
Analyze the earnings history of ImmuCell using advanced sorting and filters.
Data brought to you by Benzinga APIs
ImmuCell (ICCC) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q1 | 2021-05-13 | $-0.06 | $0.05 | -220.0 % |
| Q3 | 2020-11-12 | $-0.04 | $-0.08 | 50.0 % |
| Q2 | 2020-08-12 | $-0.11 | $-0.10 | -10.0 % |
ImmuCell (ICCC) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | 2024-08-13 | $5.47M | $3.26M | 67.9 % |
| Q3 | 2022-11-21 | $4.80M | $5.40M | -11.2 % |
| Q1 | 2022-05-12 | $6.00M | $5.40M | 11.1 % |
| Q4 | 2022-02-22 | $5.44M | $5.40M | 0.81 % |
FAQ
When is ImmuCell (NASDAQ:ICCC) reporting earnings?
ImmuCell (ICCC) is scheduled to report earnings on February 25, 2025. The last reported earnings were for reported on November 13, 2024 for Q3.
What were the latest earnings per share (EPS) for ImmuCell (NASDAQ:ICCC)?
The Actual EPS was $-0.09, which missed the estimate of $0.00.
What were ImmuCell’s (NASDAQ:ICCC) revenues?
The Actual Revenue was $6M, which beat the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.